The paroxysmal supraventricular tachycardia usmle
The paroxysmal supraventricular tachycardia usmle Paroxysmal supraventricular tachycardia (PSVT) is a common arrhythmia characterized by sudden episodes of rapid heart rate originating above the ventricles. It predominantly affects young and middle-aged individuals but can occur at any age. Understanding PSVT is crucial for medical students preparing for exams like the USMLE, as it encompasses key concepts in cardiac electrophysiology, diagnosis, and management.
The paroxysmal supraventricular tachycardia usmle PSVT occurs due to abnormal electrical pathways within the atria or the atrioventricular (AV) node. The most frequent mechanism is re-entry, where an electrical impulse re-circulates through a pathway, causing the heart rate to accelerate rapidly. This re-entrant circuit can be within the AV node itself (AV nodal re-entrant tachycardia, AVNRT) or involve accessory pathways, as in Wolff-Parkinson-White (WPW) syndrome. Differentiating between these mechanisms is essential because it influences management strategies.
The paroxysmal supraventricular tachycardia usmle Clinically, patients with PSVT often present with sudden onset and termination of palpitations, a sensation of pounding or racing heart, dizziness, and sometimes chest discomfort. The episodes tend to be brief, lasting seconds to minutes, but can recur frequently. On physical examination during an episode, the heart rate is typically between 150 to 250 beats per minute, with a regular rhythm. The physical exam may reveal a rapid, regular pulse, but often the patient appears comfortable unless the episode is prolonged or severe.
The paroxysmal supraventricular tachycardia usmle Electrocardiogram (ECG) remains the cornerstone of diagnosis. During an episode, the ECG shows a narrow QRS complex tachycardia with a rate usually between 150-250 bpm. P waves may be hidden within the QRS complexes or appear as pseudo R’ or pseudo S waves, making interpretation challenging. The absence of delta waves (which are seen in WPW) and the regularity of the rhythm help distinguish PSVT from other tachyarrhythmias.
Management begins with acute termination of the episode. Vagal maneuvers, such as the Valsalva maneuver or carotid sinus massage, are first-line because they increase vagal tone and can interrupt re-entrant circuits. If vagal maneuvers are ineffective, pharmacologic intervention with adenosine is typically employed. Adenosine acts rapidly to transiently block conduction through the AV node, often terminating AVNRT. It is administered as an intravenous bolus, with rapid infusion due to its short half-life.
In cases where pharmacologic therapy fails or if the patient has recurrent episodes, other options include beta-blockers, calcium channel blockers (like verapamil), or antiarrhythmic drugs. For definitive treatment, catheter ablation targeting the accessory pathway or the slow pathway in AVNRT offers high success rates and is considered curative. The paroxysmal supraventricular tachycardia usmle
It is important to recognize that patients with WPW syndrome who develop PSVT are at risk for sudden cardiac death if the accessory pathway conducts rapidly during atrial fibrillation. Thus, identifying WPW pattern on ECG during sinus rhythm is critical for risk stratification and management.
The paroxysmal supraventricular tachycardia usmle In summary, PSVT is a common, usually benign arrhythmia that can be effectively diagnosed with clinical features and ECG findings. Management involves vagal maneuvers, pharmacotherapy, and potentially catheter ablation, with the goal of symptom relief and prevention of recurrence.
